Literature DB >> 17632087

Activation of thromboxane receptor alpha induces expression of cyclooxygenase-2 through multiple signaling pathways in A549 human lung adenocarcinoma cells.

Jingyan Wei1, Weili Yan, Xiuling Li, Wen-Chang Chang, Hsin-Hsiung Tai.   

Abstract

Human lung adenocarcinoma A549 cells stably transfected with TPalpha (A549-TPalpha) were used to study agonist I-BOP-induced expression of cyclooxygenase-2 (COX-2) and the related mechanisms of induced expression. I-BOP, a TP agonist, induced a time- and dose-dependent expression of COX-2 in A549-TPalpha cells. The signaling pathways of I-BOP-induced COX-2 expression were elucidated by using various inhibitors of the signaling molecules. The effects of these inhibitors were assessed at protein level, enzyme activity and promoter activity of COX-2. Within MAPK family, both ERK and p38 MAPK but not JNK/SAPK pathways were involved in the induction. Other pathways such as JAK/Stat3 pathway and beta-catenin/TCF/LEF pathway also participated in the induction. The activation of key signaling molecules, ERK, p38 MAPK, CREB and NF-kappaB, involved in the COX-2 transcription was further studied at the phosphorylation step. Activation of ERK and p38 MAPK appeared to be mediated primarily by transactivation of EGFR, whereas activation of CREB and NF-kappaB was mediated by PKA, PKC and ERK. The role of CREB and NF-kappaB in I-BOP-induced COX-2 expression was further explored at the promoter level. Studies on promoter fragments and mutation of responsive motifs indicated that CRE and NF-kappaB sites are critical for the COX-2 induction. Distal NF-kappaB site is essential for the basal induction of the COX-2 transcription, whereas CRE and proximal NF-kappaB sites are important for the induced transcription. These results indicate that I-BOP-induced COX-2 expression through multiple signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17632087      PMCID: PMC1995664          DOI: 10.1016/j.bcp.2007.06.008

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  53 in total

1.  Reciprocal regulation of cyclooxygenase-2 and 15-hydroxyprostaglandin dehydrogenase expression in A549 human lung adenocarcinoma cells.

Authors:  Min Tong; Yunfei Ding; Hsin-Hsiung Tai
Journal:  Carcinogenesis       Date:  2006-04-22       Impact factor: 4.944

2.  Thromboxane A(2) regulation of endothelial cell migration, angiogenesis, and tumor metastasis.

Authors:  D Nie; M Lamberti; A Zacharek; L Li; K Szekeres; K Tang; Y Chen; K V Honn
Journal:  Biochem Biophys Res Commun       Date:  2000-01-07       Impact factor: 3.575

3.  The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis.

Authors:  G Steinbach; P M Lynch; R K Phillips; M H Wallace; E Hawk; G B Gordon; N Wakabayashi; B Saunders; Y Shen; T Fujimura; L K Su; B Levin; L Godio; S Patterson; M A Rodriguez-Bigas; S L Jester; K L King; M Schumacher; J Abbruzzese; R N DuBois; W N Hittelman; S Zimmerman; J W Sherman; G Kelloff
Journal:  N Engl J Med       Date:  2000-06-29       Impact factor: 91.245

4.  Lipoteichoic acid-induced nitric oxide synthase expression in RAW 264.7 macrophages is mediated by cyclooxygenase-2, prostaglandin E2, protein kinase A, p38 MAPK, and nuclear factor-kappaB pathways.

Authors:  Yau-Chong Chang; Pei-Chih Li; Bing-Chang Chen; Ming-Shyan Chang; Jui-Ling Wang; Wen-Ta Chiu; Chien-Huang Lin
Journal:  Cell Signal       Date:  2005-11-11       Impact factor: 4.315

5.  Glycogen synthase kinase-3 phosphorylation, T-cell factor signaling activation, and cell morphology change following stimulation of thromboxane receptor alpha.

Authors:  Weili Yan; Hsin-Hsiung Tai
Journal:  J Pharmacol Exp Ther       Date:  2005-12-13       Impact factor: 4.030

6.  Induction of prostaglandin endoperoxide synthase 2 by mitogen-activated protein kinase cascades.

Authors:  A McGinty; M Foschi; Y W Chang; J Han; M J Dunn; A Sorokin
Journal:  Biochem J       Date:  2000-12-01       Impact factor: 3.857

7.  Increased thromboxane B(2) levels are associated with lipid peroxidation and Bcl-2 expression in human lung carcinoma.

Authors:  George G Chen; Tak W Lee; Johnson H Y Yip; Hu Xu; Isa K Y Lee; Tony S K Mok; Timothy D Warner; Anthony P C Yim
Journal:  Cancer Lett       Date:  2006-03-28       Impact factor: 8.679

8.  p38 mitogen-activated protein kinase-dependent and -independent intracellular signal transduction pathways leading to apoptosis in human neutrophils.

Authors:  S C Frasch; J A Nick; V A Fadok; D L Bratton; G S Worthen; P M Henson
Journal:  J Biol Chem       Date:  1998-04-03       Impact factor: 5.157

9.  Substance P stimulates cyclooxygenase-2 and prostaglandin E2 expression through JAK-STAT activation in human colonic epithelial cells.

Authors:  Hon-Wai Koon; Dezheng Zhao; Yanai Zhan; Sang Hoon Rhee; Mary P Moyer; Charalabos Pothoulakis
Journal:  J Immunol       Date:  2006-04-15       Impact factor: 5.422

10.  Aspirin use and the risk for colorectal cancer and adenoma in male health professionals.

Authors:  E Giovannucci; E B Rimm; M J Stampfer; G A Colditz; A Ascherio; W C Willett
Journal:  Ann Intern Med       Date:  1994-08-15       Impact factor: 25.391

View more
  9 in total

Review 1.  Basic aspects of tumor cell fatty acid-regulated signaling and transcription factors.

Authors:  Andrea Comba; Yi-Hui Lin; Aldo Renato Eynard; Mirta Ana Valentich; Martín Ernesto Fernandez-Zapico; Marìa Eugenia Pasqualini
Journal:  Cancer Metastasis Rev       Date:  2011-12       Impact factor: 9.264

Review 2.  Cyclooxygenases and lipoxygenases in cancer.

Authors:  Claus Schneider; Ambra Pozzi
Journal:  Cancer Metastasis Rev       Date:  2011-12       Impact factor: 9.264

Review 3.  The thromboxane synthase and receptor signaling pathway in cancer: an emerging paradigm in cancer progression and metastasis.

Authors:  Prasanna Ekambaram; Wanyu Lambiv; Rosanna Cazzolli; Anthony W Ashton; Kenneth V Honn
Journal:  Cancer Metastasis Rev       Date:  2011-12       Impact factor: 9.264

4.  Thromboxane A2 exerts promoting effects on cell proliferation through mediating cyclooxygenase-2 signal in lung adenocarcinoma cells.

Authors:  Run-Yue Huang; Shan-Shan Li; Hui-Zhen Guo; Yu Huang; Xian Zhang; Ming-Yue Li; George Gong Chen; Xing Zeng
Journal:  J Cancer Res Clin Oncol       Date:  2014-01-03       Impact factor: 4.553

5.  Redox Factor-1 Inhibits Cyclooxygenase-2 Expression via Inhibiting of p38 MAPK in the A549 Cells.

Authors:  Dae Goon Yoo; Cuk Seong Kim; Sang Ki Lee; Hyo Shin Kim; Eun Jung Cho; Myoung Soo Park; Sang Do Lee; Jin Bong Park; Byeong Hwa Jeon
Journal:  Korean J Physiol Pharmacol       Date:  2010-06-30       Impact factor: 2.016

6.  CREB in the pathophysiology of cancer: implications for targeting transcription factors for cancer therapy.

Authors:  Kathleen M Sakamoto; David A Frank
Journal:  Clin Cancer Res       Date:  2009-04-07       Impact factor: 12.531

7.  In Vivo Cellular Imaging for Translational Medical Research.

Authors:  Ali S Arbab; Branislava Janic; Jodi Haller; Edyta Pawelczyk; Wei Liu; Joseph A Frank
Journal:  Curr Med Imaging Rev       Date:  2009-02-01

8.  Activation of thromboxane A2 receptor (TP) increases the expression of monocyte chemoattractant protein -1 (MCP-1)/chemokine (C-C motif) ligand 2 (CCL2) and recruits macrophages to promote invasion of lung cancer cells.

Authors:  Xiuling Li; Hsin-Hsiung Tai
Journal:  PLoS One       Date:  2013-01-17       Impact factor: 3.240

9.  18β-Glycyrrhetinic acid suppresses cell proliferation through inhibiting thromboxane synthase in non-small cell lung cancer.

Authors:  Run-Yue Huang; Yong-Liang Chu; Qing-Chun Huang; Xiu-Min Chen; Ze-Bo Jiang; Xian Zhang; Xing Zeng
Journal:  PLoS One       Date:  2014-04-02       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.